The life expectancy of dogs has doubled in the last 40 years, due to new therapeutic opportunities, better nutrition, and better diagnostic approaches. This positive effect, however, is coupled with a concomitant increase in neoplasms, particularly in the canine patient. Therefore, veterinarians inevitably face new issues related to these conditions, which were poorly or never investigated in the past. One of these is chemotherapy and its possible side effects on immunity, and one of the least understood aspects to date concerns the success of vaccination in canine cancer patients. Knowing the real protection against the main canine preventable infectious diseases (parvovirus infection, distemper and infectious hepatitis) of cancer dogs undergoing chemotherapy can help veterinarians fully manage their patients at such a delicate time in their and their owners’ lives. View this paper